[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338379-105":59,"doc-detail-338379-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","folate-engineered-chitosan-nanoparticles-next-generation-anticancer-nanocarriers","Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers","","Chitosan nanoparticles are highlighted as effective anticancer drug carriers owing to their ability to encapsulate hydrophobic agents, improve solubility, permeability, and bioavailability, and enable surfactant-free solubilization. The review explains how higher drug levels can be achieved at tumor sites while limiting surfactant-associated toxicity and potentially bypassing drug resistance. Folate receptor overexpression on multiple cancer types supports folate-drug conjugate nanoparticle targeting, enabling more efficient killing and better outcomes despite stable FR&alpha isoforms during treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/folate-engineered-chitosan-nanoparticles-next-generation-anticancer-nanocarriers/338379/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/folate-engineered-chitosan-nanoparticles-next-generation-anticancer-nanocarriers/338379.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are chitosan nanoparticles considered promising for anticancer drug delivery?","Question",{"text":112,"@type":113},"They can encapsulate hydrophobic anticancer molecules and improve solubility, permeability, and bioavailability, including via surfactant-free solubilization. This supports higher tumor-site drug concentration while reducing surfactant-related toxicity.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does folate engineering improve anticancer targeting?",{"text":117,"@type":113},"Many tumor cells overexpress folate receptors on their outer surface, enabling folate-drug conjugate incorporated nanoparticles to target and kill them more effectively. The review also notes evidence that FR&alpha isoforms can remain consistent during ovarian and endometrial treatment, and folate-anchored nanoparticles may overcome resistance to conventional therapy.",{"name":119,"@type":110,"acceptedAnswer":120},"What additional benefits are discussed for folate-modified chitosan nanoparticles?",{"text":121,"@type":113},"They can enhance oral absorption of medicines, particularly poorly soluble anticancer drugs, and support long-term low-dose oral metronomic scheduling. The review also summarizes techniques to create, characterize, and tailor chitosan-based nanoparticles for diverse cancer applications.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338379,1790701257,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":29,"preview_urls":146},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Kesharwani etal. Molecular Cancer (2024) 23:244 [https://doi.org/10.1186/s12943-024-02163-z](https://doi.org/10.1186/s12943-024-02163-z)  \nMolecular Cancer  \n REVIEW Open Access  \nFolate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers  \nPrashant Kesharwani1*†, Kratika Halwai 1†, Saurav Kumar Jha2†, Mohammed H. AL Mughram3, Salem Salman Almujri4, Waleed H. Almalki5 and Amirhossein Sahebkar6,7*  \nAbstract  \nChitosan nanoparticles (NPs) are well-recognized as promising vehicles for delivering anticancer drugs due to their distinctive characteristics. They have the potential to enclose hydrophobic anticancer molecules, thereby enhancing their solubilities, permeabilities, and bioavailabilities; without the use of surfactant, i.e., through surfactant-free solubilization. This allows for higher drug concentrations at the tumor sites, prevents excessive toxicity imparted by surfactants, and could circumvent drug resistance. Moreover, biomedical engineers and formulation scientists can also fabricate chitosan NPs to slowly release anticancer agents. This keeps the drugs at the tumor site longer, makes therapy more effective, and lowers the frequency of dosing. Notably, some types of cancer cells (fallopian tube, epithelial tumors of the ovary, and primary peritoneum; lung, kidney, ependymal brain, uterus, breast, colon, and malignant pleural mesothelioma) have overexpression of folate receptors (FRs) on their outer surface, which lets folate-drug conjugate–incorporated NPs to target and kill them more effectively. Strikingly, there is evidence suggesting that the excessively produced FR&αgr (isoforms of the FR) stays consistent throughout treatment in ovarian and endometrial cancer, indicating resistance to conventional treatment; and in this regard, folate-anchored chitosan NPs can overcome it and improve the therapeutic outcomes. Interestingly, overly expressed FRs are present only in certain tumor types, which makes them a promising biomarker for predicting the effectiveness of FR-targeted therapy. On the other hand, the folate-modified chitosan NPs can also enhance the oral absorption of medicines, especially anticancer drugs, and pave the way for effective and long-term low-dose oral metronomic scheduling of poorly soluble and permeable drugs. In this review, we talked briefly about the techniques used to create, characterize, and tailor chitosan-based NPs; and delved deeper into the potential applications of folate-engineered chitosan NPs in treating various cancer types.  \nKeywords Chitosan, Nanoparticles, Solubility, Nanomedicine, Anticancer efficacy, Folate receptor  \n†Prashant Kesharwani, Kratika Halwai and Saurav Kumar Jha contributed equally to this work.  \n*Correspondence:  \nPrashant Kesharwani [prashantdops@gmail.com](prashantdops@gmail.com)[ ](prashantdops@gmail.com)Amirhossein Sahebkar[amir_saheb2000@yahoo.com](amir_saheb2000@yahoo.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http:/","cbCaifzW7y2j9nk0","https://ap.wps.com/l/cbCaifzW7y2j9nk0","pdf",3794114,51,"English","# Abstract\n# Introduction","[{\"question\":\"Why are chitosan nanoparticles considered promising for anticancer drug delivery?\",\"answer\":\"They can encapsulate hydrophobic anticancer molecules and improve solubility, permeability, and bioavailability, including via surfactant-free solubilization. This supports higher tumor-site drug concentration while reducing surfactant-related toxicity.\"},{\"question\":\"How does folate engineering improve anticancer targeting?\",\"answer\":\"Many tumor cells overexpress folate receptors on their outer surface, enabling folate-drug conjugate incorporated nanoparticles to target and kill them more effectively. The review also notes evidence that FR\\u0026alpha isoforms can remain consistent during ovarian and endometrial treatment, and folate-anchored nanoparticles may overcome resistance to conventional therapy.\"},{\"question\":\"What additional benefits are discussed for folate-modified chitosan nanoparticles?\",\"answer\":\"They can enhance oral absorption of medicines, particularly poorly soluble anticancer drugs, and support long-term low-dose oral metronomic scheduling. The review also summarizes techniques to create, characterize, and tailor chitosan-based nanoparticles for diverse cancer applications.\"}]","Folate-engineered chitosan nanoparticles: next-generation anticancer nanocarriers | PDF",1790023354,129,[147,151,155,159,163,167],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f72e4e750170e35b3bed00500e0cf1c7.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3a3e060ac350b3454d5a91ddf2b7ca5.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/54716efded051f1a55e7118b6580324a.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d8f51fa66198fe2c5ad0b88d6033773a.webp",980,1301,{"page_no":24,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a04aede678866f49201b75dbdc317afc.webp",979,1300,{"page_no":29,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16885dfdd96a4760b61e7a8f03e1a197.webp",978,1299]